Used in conjunction with the reading of standard digital chest X-rays, OnGuard is said to identify solitary pulmonary nodules that may be early-stage lung cancer. The contract streamlines the process for the Veterans Affairs and other authorized federal agencies to purchase the CAD software.
Diane Hirakawa, chairman and CEO of Riverain Medical, said: “The OnGuard system will allow radiologists at Veterans Affairs hospitals across the country to better detect suspicious nodules which may indicate the presence of early-stage lung cancer thereby increasing survival rates in this deadly disease.”